HTG MOLECULAR DIAGNOSTICS IN's ticker is HTGM and the CUSIP is 40434H203. A total of 24 filers reported holding HTG MOLECULAR DIAGNOSTICS IN in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | -30.0% | 10,611 | +5.9% | 0.00% | – |
| Q2 2022 | $10,000 | -52.4% | 10,023 | -32.1% | 0.00% | – |
| Q1 2022 | $21,000 | +40.0% | 14,763 | +421.7% | 0.00% | – |
| Q4 2021 | $15,000 | -37.5% | 2,830 | -32.9% | 0.00% | – |
| Q3 2021 | $24,000 | -87.0% | 4,219 | -86.7% | 0.00% | – |
| Q2 2021 | $184,000 | +2200.0% | 31,668 | +2179.9% | 0.00% | – |
| Q1 2021 | $8,000 | -42.9% | 1,389 | -49.9% | 0.00% | – |
| Q4 2020 | $14,000 | – | 2,772 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 381,713 | $1,828,000 | 1.56% |
| Cowen Prime Services LLC | 441,918 | $2,117,000 | 0.94% |
| Nantahala Capital Management | 363,622 | $1,742,000 | 0.05% |
| GSA CAPITAL PARTNERS LLP | 45,221 | $217,000 | 0.04% |
| HighMark Wealth Management LLC | 6,666 | $32,000 | 0.03% |
| Tower Research Capital LLC (TRC) | 10,572 | $51,000 | 0.00% |
| Qube Research & Technologies Ltd | 12,034 | $58,000 | 0.00% |
| Squarepoint Ops LLC | 25,597 | $123,000 | 0.00% |
| Ironwood Financial, llc | 103 | $0 | 0.00% |
| OSAIC HOLDINGS, INC. | 24 | $0 | 0.00% |